Peptide-Coated Polycaprolactone-Benzalkonium Chloride Nanocapsules for Targeted Drug Delivery to the Pancreatic β-Cell
ACS Applied Bio Materials,
Journal Year:
2024,
Volume and Issue:
7(10), P. 6451 - 6466
Published: Sept. 24, 2024
Targeting
current
therapies
to
treat
or
prevent
the
loss
of
pancreatic
islet
β-cells
in
Type
1
Diabetes
(T1D)
may
provide
improved
efficacy
and
reduce
off-target
effects.
Current
efforts
target
β-cell
are
limited
by
a
lack
β-cell-specific
targets
inability
test
multiple
targeting
moieties
with
same
delivery
vehicle.
Here,
we
fabricate
tailorable
polycaprolactone
nanocapsule
(NC)
which
different
peptides
can
be
interchangeably
attached
for
delivery.
Incorporation
cationic
surfactant
NC
shell
allows
attachment
Exendin-4
an
antibody
ectonucleoside
triphosphate
diphosphohydrolase
3
(ENTPD3)
targeting.
The
average
size
ranges
from
250
300
nm
polydispersity
index
under
0.2.
NCs
nontoxic,
stable
media
culture,
lyophilized
reconstituted.
coated
peptide
were
taken
up
human
cadaveric
stem
cell-derived
β-like
cells
(sBC)
vitro
high
level
specificity.
Furthermore,
successfully
delivered
both
hydrophobic
hydrophilic
cargo
β-cells.
Additionally,
Exendin-4-coated
targeted
mouse
vivo.
Overall,
our
have
potential
improve
cell-targeted
drug
utilized
as
screening
platform
cell-targeting
peptides.
Language: Английский
Controlling human stem cell-derived islet composition using magnetic sorting
Alyssa M. Kelley,
No information about this author
Mira Shunkarova,
No information about this author
Marlie M. Maestas
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 21, 2024
Stem
cell-derived
islets
(SC-islets)
consists
of
multiple
hormone-producing
cell
types
and
offer
a
promising
therapeutic
avenue
for
treating
type
1
diabetes
(T1D).
Currently,
the
composition
generated
within
these
SC-islets
currently
cannot
be
controlled
via
soluble
factors
during
this
differentiation
process
consist
off-target
types.
In
study,
we
devised
magnetic-activated
sorting
(MACS)
protocol
to
enrich
CD49a,
marker
associated
with
functional
insulin-producing
β
cells.
were
from
human
pluripotent
stem
cells
(hPSCs)
using
an
adherent
then
sorted
aggregated
into
islet-like
clusters
produce
CD49a-enriched,
CD49a-depleted,
unsorted
SC-islets.
Single-cell
RNA
sequencing
(scRNA-seq)
immunostaining
revealed
that
CD49a-enriched
had
higher
proportions
improved
transcriptional
identity
compared
other
Functional
assays
demonstrated
exhibited
enhanced
glucose-stimulated
insulin
secretion
both
Language: Английский